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Abstract
Background: Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against
atherosclerosis. Although the liver is the major source of plasma apoE, extra-hepatic sources of apoE, including from
macrophages, account for up to 10% of plasma apoE levels. This study examined the contribution of macrophage-derived
apoE expression levels in diet-induced hyperlipidemia and atherosclerosis.
Methodology/Principal Findings: Hypomorphic apoE (Apoe
h/h) mice expressing wildtype mouse apoE at ,2–5% of
physiological levels in all tissues were derived by gene targeting in embryonic stem cells. Cre-mediated gene repair of
the Apoe
h/h allele in Apoe
h/hLysM-Cre mice raised apoE expression levels by 26 fold in freshly isolated peritoneal
macrophages, restoring it to 37% of levels seen in wildtype mice. Chow-fed Apoe
h/hLysM-Cre and Apoe
h/h mice
displayed similar plasma apoE and cholesterol levels (55.5362.90 mg/dl versus 62.7062.77 mg/dl, n=12). When fed
a high-cholesterol diet (HCD) for 16 weeks, Apoe
h/hLysM-Cre mice displayed a 3-fold increase in plasma apoE and
a concomitant 32% decrease in plasma cholesterol when compared to Apoe
h/h mice (602.20622.30 mg/dl versus
888.80624.99 mg/dl, n=7). On HCD, Apoe
h/hLysM-Cre mice showed increased apoE immunoreactivity in lesional
macrophages and liver-associated Kupffer cells but not hepatocytes. In addition, Apoe
h/hLysM-Cre mice developed 35%
less atherosclerotic lesions in the aortic root than Apoe
h/h mice (167610
3616610
3 mm
2 versus 259610
3656610
3 mm
2,
n=7). This difference in atherosclerosis lesions size was proportional to the observed reduction in plasma cholesterol.
Conclusions/Significance: Macrophage-derived apoE raises plasma apoE levels in response to diet-induced hyperlipidemia
and by such reduces atherosclerosis proportionally to the extent to which it lowers plasma cholesterol levels.
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Introduction
Apolipoprotein (apo) E is a multifunctional plasma glycoprotein
best known for its ability to lower plasma cholesterol and protect
against atherosclerosis [1]. As a high affinity ligand for the low-
density lipoprotein receptor (LDLR), the LDLR related protein
(LRP) and heparan sulfate proteoglycans (HSP) apoE participates
in the receptor-mediated clearance of remnant lipoproteins in the
liver [1,2]. Although the liver is the major source of plasma apoE,
studies have shown that extra-hepatic sources of apoE, including
from macrophages, account for up to 10% of plasma apoE levels
[3,4,5]. Adoptive transfer studies have shown that in Apoe
2/2
mice, even a 10% restoration of plasma apoE levels by
macrophages is sufficient to normalize plasma cholesterol levels
and prevent the formation of atherosclerosis [6,7]. Moreover, the
absence of macrophage-derived apoE is known to reduce plasma
apoE levels in both wildtype (WT) [8] and Ldlr
2/2 mice [9]. Thus,
macrophage-derived apoE contributes substantially to plasma
apoE levels. However, despite the well established atheroprotective
properties of macrophage-derived apoE [6,7], the consequences of
its deficiency on atherosclerosis remain less well understood
[8,9,10,11].
Early human and animal studies demonstrated that normal
plasma apoE levels far exceed the minimum amount required to
regulate plasma cholesterol levels [12,13,14]. In addition, macro-
phage-derived apoE was shown to accumulate within atheroma
[15] while a macrophage deficiency in apoE decreased its content
within atherosclerotic lesions [9,10]. Accordingly, the concept that
apoE may possess atheroprotective roles independent of its ability
to lower plasma cholesterol levels emerged. To address this
question, studies were designed to produce plasma apoE levels
below the threshold required to lower plasma cholesterol levels by
making use of macrophage-specific transgenic and viral human
apoE expression [16,17,18] in bone marrow transplanted Apoe
2/2
mice [16,17,18,19,20]. As such, low levels of macrophage-derived
apoE significantly reduced early fatty streak formation in
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to account for the anti-atherogenic properties of macrophage-
derived apoE is centered on its ability to promote cholesterol efflux
from macrophage foam cells [16,17,20,21,22,23]. Although results
of these studies provided important insights into the role of
macrophage-derived apoE in both plasma cholesterol homeostasis
and atherosclerosis, most were conducted in irradiated Apoe
2/2
mice using either transfected or transgenic inter-species expression
of human apoE. In addition to the unwanted effects of irradiation
[24,25] and inter-species differences in apoE activity [18,20,26],
these studies made use of Apoe
2/2 mice in which the complete
absence of apoE could be subject to compensatory effects in
metabolism and pathology [27].
Thus, this study was designed to examine the influence of
macrophage-derived apoE expression levels on the susceptibility to
diet-induced hyperlipidemia and atherosclerosis in mice that also
expressed sub-physiological levels of apoE in all tissues. We report
the development of hypomorphic apoE mice expressing ,2–5% of
WT mouse apoE in all tissues. Conditional Cre-mediated gene
repair of the hypomorphic Apoe allele increased apoE expression to
,40% of normal levels in macrophages and led to robust apoE
expression in liver-associated Kupffer cells and lesional macro-
phages when mice were fed a high cholesterol diet (HCD). Results
of our study demonstrate that macrophages respond to diet-
induced hyperlipidemia by raising plasma apoE levels and
enriching remnant lipoproteins in apoE, thereby reducing plasma
cholesterol levels. We also report that macrophage-derived apoE–
dependent atherosclerosis suppression is proportional to the extent
of plasma cholesterol lowering.
Results
Generation of Hypomorphic Apoe
h/h Mice and
Conditional Expression of apoE in Macrophages
The insertion of a neomycin (neo) resistance cassette flanked by
loxP sites into intron 3 of the WT Apoe allele resulted in the
attenuated expression of apoE as previously described in the
apoE4-like Arg-61 Apoe
h/h strain of mice [28]. The hypomorphic
effect observed in Apoe
h/h mice presumably arises from an aberrant
mRNA splicing between Apoe exon 3 and the neo cassette (Fig. 1a).
Removal of the neomycin cassette in Arg-61 Apoe
h/h mice by Cre-
mediated gene repair permanently restores normal plasma apoE
levels in plasma [28]. In this study, Apoe
h/h mice were bred to
LysM-Cre transgenic mice that restricts the expression of Cre
recombinase to the myeloid cell lineage, including mature
macrophages [29].
We first assessed the efficiency of LysM-Cre–mediated gene
repair of the hypomorphic Apoe allele. As shown in Figure 1B,
levels of apoE mRNA in peritoneal macrophages of Apoe
h/hLysM-
Cre mice were 26-fold higher than those of Apoe
h/h mice; however,
they were only 37% of apoE mRNA levels detected in
macrophages of WT mice. This result suggests that although
LysM-Cre–mediated gene repair of the hypomorphic Apoe allele
significantly increases apoE expression levels in peritoneal
macrophages, they do not return to physiological levels. We next
assessed the levels of apoE secretion in supernatants of cultured
peritoneal macrophages either with or without a pre-treatment
with an LXR agonist (Fig. 1C&D). LXR agonist pre-treatment
slightly increased the secretion of apoE in the supernatant of
macrophages of Apoe
h/h and Apoe
h/hLysM-Cre mice. We also
determined that macrophages from each group secreted 1% and
54% respectively, of basal apoE levels detected in supernatants of
WT peritoneal macrophages, mirroring the gene expression data.
Contribution of Macrophages to Plasma apoE and
Cholesterol Levels
Because macrophage-derived apoE has been shown to reduce
plasma cholesterol levels [6,7], we investigated whether a 26-fold
increase in macrophage-derived apoE expression would modulate
circulatinglevelsofplasmaapoEinApoe
h/hLysM-Cremicerelativeto
Apoe
h/hmice.Interestingly,asshowninFigure2A&B,Apoe
h/hLysM-
Cre had modestly more plasma apoE than Apoe
h/h mice when fed
a chow diet, corresponding to 1.7% and 0.8% of levels seen in WT
mice fed a chow diet, respectively. Following 16 weeks of HCD
consumption, Apoe
h/hLysM-Cre mice showed a 3-fold increase in
plasma apoE levels relative to Apoe
h/h mice (Fig. 2A&B) reaching
nearly 10% of WT levels.
This difference in circulating apoE levels impacted plasma
cholesterol levels. In both Apoe
h/hLysM-Cre and Apoe
h/h mice,
plasma cholesterol levels increased from 55.5362.90 mg/dl versus
62.7062.77 mg/dl to 602.20622.30 mg/dl versus
888.80624.99 mg/dl, respectively, after 4 weeks of HCD. Despite
gaining similar body weights (26.3360.87 g versus 25.2460.31 g
at 20 weeks of age), Apoe
h/hLysM-Cre mice maintained 33% lower
plasma cholesterol levels than Apoe
h/h mice throughout the 16
weeks of HCD consumption (p,0.001; Fig. 2C). Plasma of both
mouse models fed a chow diet displayed a normal lipoprotein
cholesterol profile in which most of the plasma cholesterol was
carried as high density lipoprotein (HDL; Fig. 2D, top panel).
However, following 16-weeks of HCD consumption, plasma from
both groups of mice displayed a lipoprotein cholesterol profile
composed mainly of very low density lipoprotein (VLDL) and low
density lipoprotein (LDL) with very little HDL. The increase in
plasma apoE levels resulted in considerably lower levels of VLDL-
cholesterol and LDL-cholesterol in Apoe
h/hLysM-Cre mice com-
pared to Apoe
h/h mice (Fig. 2D, bottom panel). Accordingly, Apoe
h/
hLysM-Cre mice had 1.5-fold less plasma apoB, mostly as a result
of a 1.4-fold reduction in plasma apoB-48 (Fig. 2D, bottom panel,
inset). Western blots of fractionated plasma also revealed plasma
apoE distributing mainly to the VLDL fractions (Fig. 2E).
Collectively, these results suggest that the contribution of
macrophage-derived apoE to the plasma apoE pool is relatively
inconsequential in chow-fed mice. However, our data demonstrate
that macrophages can contribute to significantly raise plasma
apoE levels in mice fed a HCD. This added source of plasma apoE
likely contributed to the 33% reduction in plasma cholesterol by
enriching apoB-remnant lipoproteins with apoE, thereby acceler-
ating their clearance by the liver.
Contribution of Kupffer Cell-derived apoE to Plasma
Cholesterol Homeostasis
We next wondered whether LysM-Cre–mediated gene repair of
the Apoe
h/h allele would increase apoE expression levels in Kupffer
cells, and whether this additional source of apoE could have
contributed to raise plasma apoE levels and reduce diet-induced
hypercholesterolemia in Apoe
h/hLysM-Cre mice. To test this
hypothesis, apoE mRNA expression levels and immunohistological
detection of apoE were performed in liver specimens obtained
from both mouse models. We detected a 1.5-fold increase in apoE
mRNA levels in liver extracts of Apoe
h/hLysM-Cre mice compared
to those of Apoe
h/h mice when both were fed a HCD for 16-week
(p,0.05; Fig. 3A, first panel). While no difference in mRNA
expression levels of a macrophage-specific marker CD68 were
found between the two groups, a 2.2-fold increase in CD68 was
detected in the livers of mice fed a HCD compared to their
baseline levels (p,0.05; Fig. 3A, right panel).
Macrophage apoE in Dyslipidemia & Atherosclerosis
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e35816InadditiontotheoverallincreaseinliverapoEmRNAlevels,liver
cross-sections consistently displayed regions with enhanced apoE
immunoreactivity. This additional apoE did not appear to be
associated with hepatic sinusoidal surfaces (identified with an
endothelial cell marker) nor to be derived from hepatocytes.
Quantification ofapoEimmunofluorescencelevelsfromwholeliver
cross-sections showed relatively similar levels of apoE accumulation
in liver of Apoe
h/hLysM-Cre and Apoe
h/h mice (Fig. 3 B&C). We then
examined at higher resolution the apoE immunofluorescence
associatedwithKupffercellsasidentifiedwithMac-2,amacrophage
marker (Fig. 3D). While all of the Mac-2 positive cells colocalized
with a uniformly dim level of apoE staining in Apoe
h/h mouse liver,
most Mac-2 positive cells in Apoe
h/hLysM-Cre mouse liver coloca-
lized with bright apoE staining. Quantification of the mean
fluorescence intensity of individual cells between Apoe
h/hLysM-Cre
and Apoe
h/h mice confirmed similar level of apoE in hepatocytes but
higher levels of apoE in Kupffer cells of Apoe
h/hLysM-Cre compared
to Apoe
h/h mice (Fig. 3E).
Effect of Macrophage-derived apoE Expression Levels on
Atherosclerosis
We next assessed the contribution of macrophage-derived apoE
expression levels on atherosclerosis in Apoe
h/h and Apoe
h/hLysM-Cre
micefedaHCD.AsshowninFig.4,theaorticrootoil-redOpositive
area was 35.5% smaller in Apoe
h/hLysM-Cre mice than in Apoe
h/h
mice (167610
3616610
3 mm
2 versus 259610
3656610
3 mm
2;
Figure 1. Conditional repair of the hypomorphic Apoe
h/h allele. Hypomorphic Apoe gene expression and gene repair strategies (A). Relative
Apoe gene expression levels in peritoneal macrophages collected from both groups of mice (n=4; B). ApoE secreted by peritoneal macrophages in
the presence and absence of LXR agonist pre-treatment was quantified (n=3; C) from Western Blot (D), mean6sem, **p,0.01, ***p,0.001; control is
media without macrophages.
doi:10.1371/journal.pone.0035816.g001
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areatothatoftheaorticrootwallarea(Fig.4D)revealedthatinboth
groups of mice, the atheroma within the aortic root contained the
same percentage of neutral lipids (Fig. 4E). In addition, in Apoe
h/h
mice but not in Apoe
h/hLysM-Cre mice, the oil-red O positive area
was directly proportional to plasma cholesterol levels (Fig. 4F;
r
2=0.86, p,0.01, and r
2=0.06, respectively).
Additional characterizations of aortic root atheromas with
immunofluorescence microscopy (Fig. 5) revealed 46% less macro-
phage positive area in Apoe
h/hLysM-Cre mice than in Apoe
h/h mice
(141610
3616610
3 mm
2 versus 259610
3612610
3 mm
2,p ,0.01;
Fig.5A,B&F).However,whennormalizedtotheaorticrootintimae
area (Fig. 5E), thelesions inboth groups ofmice containedthe same
percentage of macrophages (Fig. 5G). We also observed a 2.4-fold
increase in apoE fluorescence intensity within the atheroma of
Apoe
h/hLysM-Cre mice compared to that of Apoe
h/h mice
(465.3681.2a.u./mm
2 versus 190.8625.9a.u./mm
2, p=0.01;
Fig. 5C,D&H).
To determine whether macrophage-derived apoE in atheroma
had a local effect on plaque composition, we assessed the presence
of smooth muscle cells and collagen levels in aortic root lesions of
both mouse models. As shown in Figure 6A&B, the immunore-
activity for smooth muscle a-actin in the intimae of the lesions
confirmed the presence of fibrous caps in both groups of mice. In
addition, we found a similar percentage of total collagen content in
the lesions of both Apoe
h/hLysM-Cre and Apoe
h/h mice (44.064.6%
versus 43.164.7%; Fig. 6C–H). Taken together, these results
demonstrate that despite a 40% decrease in lesion area and two-
fold increase in apoE immunoreactivity, the lesions of Apoe
h/
hLysM-Cre mice were at a similar stage of complexity as those of
Apoe
h/h mice.
Discussion
This study examined the contribution of macrophage-derived
apoE expression levels on the modulation of diet-induced
hypercholesterolemia and atherosclerosis. As such we created
mouse models in which apoE was expressed either at 1.4% or 37%
of normal levels in myeloid derived cells and in which all other
tissues also expressed sub-physiological levels of apoE. A major
finding of this study is that macrophages can respond to diet-
induced hypercholesterolemia by raising plasma apoE levels and
thereby reduce plasma cholesterol levels and atherosclerosis. In
Figure 2. Plasma apoE and lipid levels. Representative Western blot (A) and quantification (B; n=3) of the band intensity of plasma apoE from
wild type (WT), Apoe
2/2 (E
2/2), Apoe
h/h and Apoe
h/hLysM-Cre mice either fed a chow diet or a high cholesterol diet (HCD); mean6sem, two-way
ANOVA Bonferonni post-tests, **p,0.01 and t-test #p,0.05. Plasma cholesterol (n=7; mean6sem, one-way ANOVA post-test, ***p,0.001; C) and
lipoprotein cholesterol distribution (pooled of 7 mice; D) are shown; inset: Western blot of apoB and quantification (n=3); mean6sem, two-way
ANOVA Bonferonni post-tests, **p,0.01, ***p,0.001. Representative Western Blot of apoE distribution in lipoprotein fractions (E).
doi:10.1371/journal.pone.0035816.g002
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produced by Kupffer cells in the setting of hypercholesterolemia.
Finally, we demonstrate that a 26-fold difference in macrophage-
derived apoE expression and its accumulation in atheroma are not
proportionally effective in regulating the progression and com-
plexity of advanced atherosclerosis.
ConditionalCre-mediatedgenerepairofthefloxedhypomorphic
apoE allele in Apoe
h/h mice expressing the LysM-Cre transgene
offered an opportunity to restrict an increase in apoE expression to
myeloid-derived cells including peritoneal macrophages and liver-
associated Kupffer cells while maintaining very low levels of apoE
expression in all other tissues. LysM-Cre–mediated gene recombi-
nationhasbeenshowntobehighlyefficientinmaturemacrophages
and granulocytes and to a lower extent in CD11c+ splenic dendritic
cells [29]. As shown in Fig. 1, levels of apoE mRNA in peritoneal
macrophages of Apoe
h/hLysM-Cre mice were 26-fold higher than in
Apoe
h/h mice. However, these levels were only 37% of apoE
expression levels detected in peritoneal macrophages of WT mice.
This result suggests that although Cre-mediated gene repair of the
hypomorphic allele significantly increases apoE expression levels in
macrophages of Apoe
h/hLysM-Cre mice, they do not return to
normal physiological levels. A potential explanation for this effect
can be derived from studies of Xu et al. who have previously
suggestedthatelementsofretentionandsplicingwithinApoeintron3
serve to control apoE expression in neurons [30]. Thus, the
additional genetic material of the loxP site comprised of approxi-
mately 90 base pairs that remains within Apoe intron 3 of the Cre-
deleted hypomorphic apoE allele is likely responsible for preventing
a full restoration of apoE expression levels in macrophages of Apoe
h/
hLysM-Cre mice.
Our models offered several advantages over existing models that
previouslyservedtoaddresstheroleofmacrophage-derivedapoEin
hyperlipidemiaandatherosclerosis.Firstandforemost,ourmodelis
the first to offer the unique possibility to study the effects of
macrophage-derived apoE expression levels in the context of very
low levels of hepatocyte-derived apoE expression, thus avoiding
potential systemic compensations observed in conventional knock-
out models [27]. Comparing Apoe
h/h and Apoe
h/hLysM-Cre mice
allowed us to study macrophages with a 26-fold difference in apoE
expression levels while all other cells expressed similarly reduced
apoE expression levels. Secondly, our models avoided the use of
transgenicexpressionofapoEfromotherspeciesandtheuseofviral
transfection systems to generate macrophages that could have
varying apoE expression levels. It is noteworthy to mention that
Figure 3. ApoE expression by liver and associated Kupffer cells. Relative CD68 (a macrophage marker) and Apoe gene expression were
compared from whole liver extract of Apoe
h/h and Apoe
h/hLysM-Cre mice (n=4 for baseline and n=7 for 16-week HCD, mean6sem, *p,0.05,
**p,0.01; A). Relative apoE protein was also quantified and compared from immunofluorescently labeled liver cross-sections (10 mm thick) after 16
weeks of HCD (mean fluorescence intensity (MFI); n=7, mean6sem; B). Representative images of whole liver cross-sections show apoE (red)
surrounding hepatic sinusoidal surfaces (identified with an endothelial cell marker: VE-cadherin in green), C; scale bar=100 mm). Higher resolution
images demonstrate higher apoE MFI associated with Kupffer cells in Apoe
h/hLysM-Cre than in Apoe
h/h mice (D; Mac-2, a macrophage marker, green;
scale bar=30 mm; white arrows point at individual kupffer cells). The apoE MFI per Kupffer cells and hepatocytes were quantified for both groups of
mice and the relative ratio calculated (**p,0.01, ****p,0.0001; E).
doi:10.1371/journal.pone.0035816.g003
Figure 4. Macrophage-derived apoE levels in atherosclerosis. Histological sections of oil-red-O stained aortic roots from Apoe
h/hLysM-Cre (A)
and Apoe
h/h mice (B; scale bar=250 mm). Quantification of oil-red-O positive area (n=7; mean6sem, **P,0.01; C), aortic wall area (D), and % of oil-
red-O (E). Correlation analysis between oil-red-O area and plasma cholesterol (n=14; **P,0.01; F).
doi:10.1371/journal.pone.0035816.g004
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lipoprotein clearance in mice particularly in response to diet-
induced hypercholesterolemia due to its lower affinity for murine
LDL receptors [18,20,26]. In addition, the transfection of macro-
phages with an apoE-expressing retrovirus was shown to result in
high degrees of variability in the level of apoE expression by
macrophages [19]. In contrast, in our study, we consistently
observed either 1.4% or 37% of normal apoE expression levels in
peritoneal macrophages ofApoe
h/h mice and Apoe
h/hLysM-Cre mice,
respectively, when compared to WT mouse macrophages (Fig 1B).
Moreover, all lesional macrophages appeared to uniformly express
apoE in atheroma of Apoe
h/hLysM-Cre mice (Fig 5A&C). Thus, our
model of macrophage-derived murine apoE benefits from a normal
receptor-ligand affinity and a uniform expression level by all tissue
macrophages including Kupffer cells and lesional macrophages.
By avoiding bone marrow transplantation as a means to restore
macrophage apoE expression in Apoe
2/2 mice, our approach
allowed the study of mice with no previous experimental
manipulation including lethal irradiation and the expansion of
marrow-derived donor cells. Thus, our models were not subject to
possible effects of gamma irradiation on liver function that could
cause neutral lipid accumulation; nor to possible effects on the
vasculature leading to regional differences in atherosclerosis
susceptibility [24,25]. Our approach thereby enabled us to
maintain an unaltered physiological environment.
Interestingly, the conditional repair of the hypomorphic allele in
Apoe
h/hLysM-Cre mice raised plasma apoE levels only marginally
(1.7% of WT) when the mice were fed a chow diet. In contrast,
plasma apoE levels in Apoe
h/hLysM-Cre mice increased to nearly
10% of WT levels when mice were fed a HCD. This additional
source of apoE did not significantly alter plasma lipid levels or the
lipoprotein cholesterol profile of chow-fed mice. However, in mice
fed a HCD, the more robust increase in plasma apoE contributed
to reduce plasma cholesterol levels by 30% and apoB48 levels by
1.4 fold in Apoe
h/hLysM-Cre mice compared to Apoe
h/h mice.
Hepatocyte-derived apoE is the main source of plasma apoE
and it has been shown to be the most effective in mediating the
clearance of remnant lipoproteins [31]. However, the role of
Kupffer cell-derived apoE in remnant lipoprotein clearance is not
well understood. It has been suggested that in the mouse, up to
20% of all tissue macrophages exist as Kupffer cells in the liver
[32]. As such, it is possible that the additional amount of apoE
observed in the plasma of Apoe
h/hLysM-Cre mice relative to Apoe
h/h
mice fed a HCD was derived at least in part from Kupffer cells. In
support of this, we found a 1.5-fold increase in apoE mRNA
expression in the liver of Apoe
h/hLysM-Cre mice relative to Apoe
h/h
mice (Fig. 3A). We reasoned that this additional amount of apoE
expression could have derived from Kupffer cells. A similar
expression level of the macrophage/Kupffer cell marker CD68 in
the liver of both groups of mice ruled out the possibility that the
increased apoE expression was simply due to a greater number of
Kupffer cells present in the liver of Apoe
h/hLysM-Cre mice. Thus,
increased expression of apoE by Kupffer cells in Apoe
h/hLysM-Cre
mice is likely responsible for enhanced apoE expression between
the two groups of mouse livers. Diet-induced hypercholesterolemia
has previously been shown to induce the formation of hepatic
foam cells [33]. Thus, it is tempting to speculate that Kupffer cells
up-regulated apoE expression due to an excess absorption of
dietary cholesterol, similar to what has been described in
cholesterol-loaded macrophages [22].
Immunohistological detection of apoE in the livers of Apoe
h/
hLysM-Cre mice confirmed that expression of Cre recombinase had
remainedrestrictedtomyeloidcelllineagesashepatocytesdisplayed
similarly reduced staining intensity for apoE in both groups of mice,
while Mac-2 positive cells displayed enhanced apoE immunoreac-
tivity only in livers of Apoe
h/hLysM-Cre mice. However, quantifica-
tionoftotalanti-apoEimmunofluorescenceintensityinliversections
of both mouse models showed no significant differences in the
content of liver apoE. It is possible that the production of apoE by
hepatocytes,albeitatreducedlevelsand/orthelowsensitivityofour
immunofluorescencetechnique,maskedthecontributionofKupffer
cell-derived apoE at least at the protein level in the liver of Apoe
h/
hLysM-Cre mice. Alternatively, it is possible that apoE produced by
Kupffer cellscontributed principally to enrich remnantlipoproteins
Figure 5. Lesional macrophage-derived apoE. Immunofluorescent images of Apoe
h/hLysM-Cre (A,C) and Apoe
h/h mice (B,D; scale bar=250 mm)
aortic roots; anti-Mac-2 (green), and apoE (red). Quantification of lesion area (E), macrophage positive and % of area (F–G); n=7. Quantification of
apoE fluorescence intensity (FI), (H); n=7, mean6sem, *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0035816.g005
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levels. Through further lipolytic catabolism in circulation, smaller
remnant lipoproteins enriched with apoE could have been more
effectively sequestered in the Space of Disse and eliminated by
receptor-mediated internalization and degradation in liver hepato-
cytes.
Yu et al. suggested that while hepatic secretion of apoE
contributes to the clearance of remnant lipoproteins, the process
can occur in the absence of hepatic apoE secretion and
enrichment of the space of Disse [34]. In fact, these studies found
that the livers of WT and Apoe
2/2 mice had the same clearance
capacity for apoE-containing remnant lipoproteins. However,
livers of Apoe
2/2 mice were incapable of removing apoE-free
remnant lipoproteins, while the livers of WT mice showed only
12% efficiency [34]. This suggests that apoE enrichment of
remnant lipoproteins in circulation represents an important step
for their clearance by the liver. The lack of a significant increase in
liver-associated apoE in Apoe
h/hLysM-Cre mice implies that a local
accumulation of apoE in their livers did not play a major role in
accelerating remnant lipoprotein clearance. In contrast, our results
suggest that Kupffer cell-derived apoE contributed to reduce levels
of plasma apoB-48 lipoproteins by enriching them with apoE,
thereby enhancing their removal from plasma in Apoe
h/hLysM-Cre
mice fed a HCD.
Results of our study also demonstrate that atherosclerotic lesion
size is directly proportional to plasma cholesterol levels in Apoe
h/h
mice but not in Apoe
h/hLysM-Cre mice. Similar results were
uncovered when atheroma were examined for the content in
smooth muscle cells and collagen, suggesting that an accumulation
of apoE within lesions of Apoe
h/hLysM-Cre mice did not provide
further protection against atherosclerosis progression than did
a lower plasma cholesterol level.
While the local production of apoE by lesional macrophages has
been suggested as a major source of apoE within the vessel wall
[15], others have found evidence that plasma apoE diffuses into
the vessel walls [26]. In Apoe
h/hLysM-Cre mice, the accumulation
of apoE in the vessel wall likely derived from both lesional
macrophages and plasma lipoprotein infiltration. The enrichment
of circulating VLDL and LDL with apoE could have contributed,
through their diffusion into the vascular wall, to the increased
apoE content within atheroma of Apoe
h/hLysM-Cre mice. The
presence of apoE on apoB-containing lipoproteins could have also
increased their retention within the vascular wall [35,36]. Such
pro-atherogenic functions of apoE have previously been reported
in mouse models of apoE-deficient macrophages [9,11]. As such, it
is conceivable that lesion-associated apoE could promote athero-
sclerosis by mediating the retention of lipoproteins, thereby
contributing to foam cell formation in the arterial wall.
Thus, despite a 2.4-fold increase in apoE immunoreactivity in
the vessel wall, we found no apparent change in the cellular
composition of the atheroma between the two groups of mice.
Alternatively, the use of an atherogenic diet containing cholate
could have induced far too severe of a hypercholesterolemia that
may have overwhelmed the anti-atherogenic properties of
macrophage-derived apoE. It is also possible that the lack of an
HDL component in the plasma of our hyperlipidemic mice failed
to activate the reverse cholesterol transport properties of apoE.
Alternatively, it is also possible that sub-physiological levels of
apoE expression by macrophages are completely competent in
effecting anti-atherosclerotic functions of apoE. A point of support
to this is the results by Hasty el al. who demonstrated in a model of
viral apoE transduction that low levels of macrophage apoE
expression that did not reduce plasma cholesterol in mice
nonetheless retarded atherosclerosis development. However, the
effect only occurred in early lesion formation and did not persist in
advanced lesions that contained other vascular cells [19]. Our data
reveal that low levels of macrophage-derived apoE can effectively
control the progression of advanced atherosclerosis in which cells
other than foam cells accumulate.
In conclusion, results of our study demonstrate that macro-
phages including liver-associated Kupffer cells raise plasma apoE
levels in response to diet-induced hyperlipidemia. This source of
apoE enriches remnant lipoproteins with apoE and reduces
plasma cholesterol levels. We also demonstrate that in our model,
macrophage-derived apoE decreases atherosclerosis but only to
the extent to which it lowers plasma cholesterol levels.
Materials and Methods
Materials
All chemicals and reagents were purchased from Sigma-Aldrich,
MO, unless otherwise stated.
Generation of Hypomorphic Apoe
h/h Mice Expressing
Wildtype Mouse ApoE
A gene targeting vector that served to create hypomorphic apoE
mice expressing an apoE4-like form of mouse apoE that contains
a substitution of an arginine for a threonine at residue 61 (ApoeR
h/h
mice [37]), was modified to create hypomorphic apoE mice that
would express reduced levels of wildtype apoE containing
a threonine at position 61. Hypomorphic apoE mice expressing
wildtype apoE were derived by homologous recombination of the
targeting vector in embryonic stem cells as previously described
[28]. Heterozygous Apoe
h/wt mice were bred to C57BL/6J mice for
12 generations and offspring were intercrossed to create homo-
zygous Apoe
h/h mice.
Conditional Cre-mediated Gene Repair of the
Hypomorphic Apoe Allele in Macrophages
Apoe
h/h mice were bred to LysM-Cre transgenic mice on
a C57BL/6J background (The Jackson Laboratory, Bar Harbor,
ME) that restrict the expression of Cre recombinase to the myeloid
cell lineage, including blood monocytes, mature macrophages, and
granulocytes [29]. This enables the conditional repair of the
hypomorphic Apoe allele in macrophages. The mice were weaned
at 21 days, housed in a barrier facility with a 12-h light and 12-h
dark cycle, and fed a chow diet containing 4.2% fat (Harlan
Teklad, Madison, WI). At 4 weeks of age, all mice were fed the
‘‘Paigen’’ diet containing 1.25% Cholesterol, 3.5% Coconut Oil,
and 7.5% Cocao Butter (Research Diets Inc., New Brunswick, NJ)
for 16 weeks. All procedures were approved by the San Francisco
Veterans Administration Medical Center committee for animal
care and welfare.
Figure 6. Atherosclerotic plaque composition. Immunofluorescent images of Apoe
h/hLysM-Cre (A) and Apoe
h/h mice (B; scale bar=50 mm)
aortic roots; anti-smooth-muscle-cell-a-actin (SMCs, red), anti-Mac-2 (Macrophages, green) and nuclei (blue). Sirius Red stained aortic roots
(brightfield (C–D) and polarized light (E–F)) from Apoe
h/hLysM-Cre (C,E) and Apoe
h/h mice (D,F); (scale bar=250 mm). Collagen quantification (G–H,
n=7, mean6sem).
doi:10.1371/journal.pone.0035816.g006
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Blood was collected from 4, 8, 12, 16, and 20 week-old mice
fasting overnight. Mice were anesthetized with either isoflurane
inhalation or Avertin (Tribromoethanol), and bled by retro-orbital
or heart puncture. Plasma was isolated by centrifuging blood
samples for 10 mins at 4000 rpm and stored at 280uC until
performing measurements. Mice were perfused via heart puncture
with ice-cold PBS containing ProtectRNA RNAse Inhibitor
(Sigma; 1.5 ml/min for 10 min). The aortic root and half of the
top right liver lobe were embedded in Tissue-Tek O.C.T.
cryosectioning compound (Sakura Finetek, Japan), and flash
frozen in liquid N2. Tissue blocks were cut into 10 mm-thick
sections. The other half liver lobe were excised and flash frozen in
liquid N2 for RNA extraction.
Plasma Lipid and Lipoprotein Fractionation
Plasma lipoproteins were fractionated by fast protein liquid
chromatography (FPLC) on a Superose 6 GL 10/30 column (GE
Healthcare, NJ). For FPLC, plasmas were pooled from 7 mice/
group prior to fractionation. Colorimetric assays were used to
measure cholesterol in plasma and FPLC fractions according to
the manufacturer’s instructions (Cholesterol E, Wako, VA).
Colorimetric assays were measured with a VersaMax microplate
reader (Molecular Devices Corporation, Sunnyvale, CA).
Western Blot Analysis of apoE and apoB
Plasma and FPLC fractions (from 4 and 20 week-old mice) were
subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE;
3–15% gels) and transferred to nitrocellulose membranes (Bio-Rad
Laboratories, CA). Plasma samples from 4 (Baseline) and 20 week-
old mice (16-week HCD) were also subjected to SDS-PAGE on
12% mini-gels and transferred to nitrocellulose membranes.
Western blots were incubated with primary antibodies: rabbit
anti-mouse apoE (1:10,000, [37]) and apoB (1:10,000, [28]),
followed by detection with IRDye 680 LT goat anti-rabbit
antibody (1:5000, LI-COR Biosciences, NE). Membranes were
scanned and quantified on the Odyssey infrared imaging system
(LI-COR Biosciences, NE). Values were expressed as fold-
increased.
Histological Quantification of Atherosclerosis
Beginning at the base of the aortic root, sections were cut at
10 mm thickness, collected, and arranged in 3 sections per slide.
Atherosclerotic lesions in the aortic root were quantified by
staining with oil-red O to reveal neutral lipids in 3 cross-sections,
50 mm apart, and counterstained with hematoxylin. Adjacent
sections were stained with Sirius red counterstained with Fast-
green to reveal collagen. Slides were mounted on a Zeiss
AxioObserver Z1 microscope (Carl Zeiss Microimaging inc.,
Thornwood, NY) and images captured with a Retiga-SRV CCD
camera equipped with RGB color filter (Qimaging, Surrey, BC,
Canada). Collagen types I and III were visualized with a circular
polarizer. Surface areas were quantified with Metamorph software
(Molecular Devices Inc).
Immunofluorescence Characterization of Aortic Root
Lesions and Liver Sections
Formalin fixed and glycine quenched cross-sections of the aortic
root and liver were permeabilized for 5 min with 0.5% Saponin in
PBS. Non-specific labeling was blocked with 10% donkey serum in
PBS with 0.1% Saponin for 2 h at RT. Aortic root sections were
simultaneously incubated with rat anti-Mac-2 (1:1000, Cedarlane
Labs Ltd., ON, CA) and rabbit anti-apoE (1:200) overnight at 4uC
or mouse anti-smooth muscle a-actin antibody conjugated to Cy3
(1:200) for 2 hrs at RT in antibody buffer solution (solution of
sodium citrate (SSC) supplemented with 2% donkey serum, 0.1%
BSA and 0.1% Saponin). Liver sections were simultaneously
incubated with rabbit anti-apoE (1:1000) and either rat anti-Mac-2
(1:1000) or goat anti-VE-Cadherin (1:200, Santa Cruz Bio-
technology, Inc., CA). After three 5 min-washes with 0.1%
Saponin SSC, sections were incubated in antibody buffer contain-
ing Alexa488 conjugated donkey anti-rat or anti-goat and
Alexa594 conjugated anti-rabbit secondary antibodies (1:1000;
Invitrogen) for 2 h at RT. Following a 365 min-wash with 0.1%
Saponin SSC, the nuclei were stained with Hoechst 33342
(1:5,000; Invitrogen) and slides mounted in SlowFade Gold
(Invitrogen). Images of each combination of up to triple labels
were acquired with a Zeiss AxioObserver microscope (as described
above) and images quantified with Metamorph software (Molec-
ular Devices Inc). For individual cell immunofluorescence intensity
quantification, a region of interest was first drawn using as a guide,
a cell specific marker (Mac-2 for Kupffer cells and non-Mac-2 for
hepatocytes) and the mean fluorescence intensity for this region
calculated. For each mouse, we averaged the results from 10
randomly chosen cells. Controls for cross-reactivity between
primary antibody and secondary antibody of a different species
were all negative. Clear separation of each channel was also
verified by omitting one of the primary antibodies.
In-vitro Peritoneal Macrophage Cell-culture
Peritoneal macrophages were extracted from C57BL/6J, Apoe
h/h
LysM-Cre and Apoe
h/h mice after treatment with Concanavalin A
and plated in 6-well tissue culture plates. Cells were allowed to
grow to confluence in Dulbecco’s Modified Eagle Medium
(DMEM; Cellgro, Manassas, VA) supplemented with 20% L-Cell
Conditioned Media, 10% fetal bovine serum (FBS, Invitrogen).
The cells were first incubated for 48 h with 50 mg/mL of human
acetylated LDL (acLDL) (BTI, Stoughton, MA) and for 24 h with
3 mM of LXR agonist T0901317 (Cayman Chemical, Ann Arbor,
MI) then incubated in DMEM supplemented with 10% Lipopro-
tein depleted bovine serum for 60hrs, in the absence of exogenous
apoE. Media’s were collected and cells lysed with RIPA buffer.
RNA Extraction and Isolation
RNA was extracted from flash frozen livers and cultured
peritoneal macrophages using the RNeasy Mini Kit (Qiagen Inc.,
CA), with a DNase step according to the manufacturer’s
instructions. Liver tissue homogenization was performed with
a Tissue-Tearor (Biospec Products Inc, OK). Quantities of RNA
were measured using NanoDropTM 2000 (Thermo Scientific,
DE).
Analysis of Gene Expression by Quantitative Real-time
RT-PCR
Quantitative Real-time reverse transcriptase polymerase chain
reaction (qRT-PCR) was used to analyze gene expression levels in
cultured peritoneal macrophages. Gene expression was deter-
mined with an ABI Prism 7900 (Applied Biosystems, Foster City,
CA) using in house designed primer pairs and SyBr green
reactions (Applied Biosystems). cDNA was reverse-transcribed
from 100ng total RNA (iScript, Bio-Rad Laboratories). Two mLo f
diluted (1:10) cDNA template were used in each qRT-PCR
reaction. ApoE gene expression was normalized to the house-
keeping gene Cyclophilin A and calculated according to the
2
2DDCt method. All experiments were performed in triplicate.
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Data were analyzed with GraphPad Prism 5 software
(GraphPad Software Inc., La Jolla, CA) using two-tailed Student
t tests unless otherwise stated. A difference with a P value of ,0.05
was considered significant.
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